Vaccine

Vaccine is a peer-reviewed medical journal, published by Elsevier. It is targeted towards medical professionals who are interested in vaccines and vaccination. It describes itself as "an interface between academics, those in research and development, and workers in the field. Relevant topics range from basic research through to applications, safety and legislation."

Publisher
Elsevier
Country
USA
Impact factor
3.616 (2009)

Some content from Wikipedia, licensed under CC BY-SA

Medical research

Virtual reality could help flu vaccination rates

Using a virtual reality simulation to show how flu spreads and its impact on others could be a way to encourage more people to get a flu vaccination, according to a study by researchers at the University of Georgia and the ...

Vaccination

Inoculating against the spread of viral misinformation

In a year that has seen the largest measles outbreak in the US in more than two decades, the role of social media in giving a platform to unscientific anti-vaccine messages and organizations has become a flashpoint.

Cardiology

Researchers develop vaccine to treat high cholesterol

A team of researchers at the University of New Mexico (UNM) and the National Institutes of Health (NIH) have developed a vaccine to treat high cholesterol. The vaccine, which targets a molecule called PCSK9, a protein involved ...

Diseases, Conditions, Syndromes

Developing a better flu vaccine

Johns Hopkins Bloomberg School of Public Health researchers say they have developed a method that could make a nasal spray flu vaccine effective for those under two and over 49 - two groups for which the vaccine is not approved.

Pediatrics

Children not immunised due to socioeconomic barriers

Almost one in 10 Australian infants are at risk of severe infections because they are not up-to-date with their immunisations. According to new research at the University of Adelaide, infants from socially disadvantaged backgrounds ...

Diseases, Conditions, Syndromes

Study announces a durable vaccine for Ebola

A cytomegalovirus (CMV)-based vaccine provides long-lasting protective immunity against Ebola virus, and has potential for development as a disseminating vaccine strategy to prevent ebolavirus infection of wild African ape ...

page 1 from 10